Page last updated: 16 June, 2021, 10:12am Central nervous system Tramadol paracetamol MSEMOC position statementDownload Fentanyl immediate release preparations MSEMOC position statementDownload Oxycodone naloxone MSEMOC position statementDownload Cannabis products MSEMOC position statementDownload Melatonin Slenyto® for the treatment of insomniaDownload Pathway for PbR excluded drugs for preventing chronic migraine in adultsDownload Adult Headache pathwayDownload Galcanezumab for preventing migraine (NICE TA659) position statementDownload Low dose naltrexone MSEMOC position statementDownload Co-proxamol MSEMOC position statementDownload Lidocaine plasters MSEMOC position statementDownload Erenumab for preventing migraine (NICE TA682) position statementDownload
